Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABATE Infection Trial: Decolonization to reduce HAIs
NCT02063867Completed
- Sponsor
- University of California, Irvine
- Start
- Apr 2014
- Primary completion
- Feb 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of chlorhexidine + cymenol gel and mupirocin in Healthcare-associated infection (HAI), Staphylococcus aureus infection, Enterococcus infection and 1 more (2 arms), sponsored by University of California, Irvine. Primary endpoint: Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococcus clinical cultures at 21 months. Started Apr 2014; status: completed.
02
Drugs
chlorhexidine + cymenol gelmupirocin
03
Conditions
Healthcare-associated infection (HAI)Staphylococcus aureus infectionEnterococcus infectionInfection
Beyond the preview
Go deeper on NCT02063867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02063867.